0. Advocacy Graphic

ADVOCACY NEWS


  • September 10, 2018

    ASAM Responds to Medicare Physician Fee Schedule, Urges CMS to Reform Payment Models to Address Opioid Addiction

    Today, the American Society of Addiction Medicine (ASAM) submitted comments to the Centers for Medicare & Medicaid Services (CMS) that recommend revisions to the proposed 2019 Medicare Physician Fee Schedule (MPFS) that will improve the delivery of evidence-based addiction medicine to combat the nation’s opioid overdose epidemic.
  • August 20, 2018

    Addiction Medicine Specialists Urge Senate Leaders to Pass Comprehensive Opioid Legislation

    The American Society of Addiction Medicine (ASAM) and 28 of its chapters –– sent a letter to Senate Majority Leader Mitch McConnell and Senator Minority Leader Chuck Schumer urging the US Senate to pass swiftly comprehensive legislation to address the opioid overdose epidemic.
  • August 2, 2018

    Countering the U.S. Opioid Epidemic

    To improve coordination and accelerate the pace of change, the American Society of Addiction Medicine (ASAM) is partnering with the National Academy of Medicine and more than 30 other organizations to form an Action Collaborative on Countering the U.S. Opioid Epidemic.
  • July 24, 2018

    ASAM Applauds Congressional Oversight Hearing on Addiction Treatment Facilities and Calls on Senate to Act Quickly on Legislation

    The American Society of Addiction Medicine (ASAM) applauds the House Energy and Commerce Subcommittee on Oversight and Investigations for reviewing advertising and marketing practices of addiction treatment programs in the United States (US) in its hearing titled “Examining Advertising and Marketing Practices within the Substance Use Treatment Industry.” The hearing is part of Congress’s ongoing effort to ensure addiction treatment facilities abide by appropriate standards and provide evidence-based treatment.
  • July 5, 2018

    ASAM, AAPA, AANP, and AOAAM Request Meeting with DOJ Regarding Recent Enforcement Actions

    On July 3, the American Society of Addiction Medicine (ASAM), American Academy of PAs (AAPA), American Association of Nurse Practitioners (AANP), and American Osteopathic Academy of Addiction Medicine (AOAAM), approved providers of DATA 2000 training, issued a letter to Attorney General Jeff Sessions thanking the Department of Justice (DOJ) for identifying individuals who may be committing opioid-related criminal activity and health care fraud involving patients with addiction and expressing the need to work together so such actions do not have unintended consequences that dissuade clinicians from prescribing buprenorphine and leave patients without treatment should their practitioners’ offices be closed.
  • June 27, 2018

    NASTAD Joins the Coalition to Stop Opioid Overdose

    The Coalition to Stop Opioid Overdose (CSOO) enthusiastically welcomes NASTAD (National Alliance of State and Territorial AIDS Directors) as a new member of the coalition. NASTAD is an association that represents public health officials who administer HIV and hepatitis programs in all 50 U.S. states and around the world. NASTAD seeks to end the intersecting epidemics of HIV and viral hepatitis by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.
  • June 22, 2018

    Addiction Medicine Community Applauds Passage of House’s Bipartisan Legislative Package to Combat the Opioid Addiction & Overdose Epidemic

    The American Society of Addiction Medicine (ASAM) applauds the House of Representatives for its action this week to pass the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), the Overdose Prevention and Patient Safety (OPPS) Act (H.R. 6082), and the IMD Care Act (H.R. 5797).
  • June 4, 2018

    The US Department of Justice Drug Enforcement Administration Diversion Control Division Released Statement Clarifying the Use of Telemedicine for Medication Assisted Treatment (MAT)

    The US Department of Justice Drug Enforcement Administration Diversion Control Division Released Statement Clarifying the Use of Telemedicine for Medication Assisted Treatment (MAT) On May 15, the Drug Enforcement Agency (DEA) Drug Diversion Division issued an email alert reiterating its position on the prescribing of controlled....